MDRX (Veradigm) Non Operating Income: $-128.5 Mil (TTM As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDRX Veradigm Inc MDRX
23 GF Score
Price $4.65
View Full Analysis

What is Veradigm Non Operating Income?

Veradigm MDRX -4.12% 23 Non Operating Income is $-128.5 Mil as of Dec. 2022. GuruFocus rates MDRX with a GF Score™ of 23/100.

Non Operating Income is income or expense that comes from miscellaneous sources. Veradigm's Non Operating Income for the six months ended in Dec. 2022 was $-42.8 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2022 was $-128.5 Mil.

Veradigm Non Operating Income Related Terms

Veradigm Non Operating Income Historical Data

* Premium members only.

The historical data trend for Veradigm's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veradigm Non Operating Income Chart

Veradigm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -175.43 3.12 93.12 -42.84 -128.50

Veradigm Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 May09 May10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -175.43 3.12 93.12 -42.84 -128.50
MDRX
23GF Score
Veradigm Inc MDRX
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veradigm Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2022 was $-128.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $-128.5 Mil mean?
Veradigm (MDRX) has a Non Operating Income of $-128.5 Mil as of Dec. 2022. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Veradigm and its competitors.
Is Veradigm's Non Operating Income too high?
Veradigm's current Non Operating Income is $-128.5 Mil. Overall, Veradigm has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Non Operating Income compare to WEAV and PHR?
Veradigm's Non Operating Income of $-128.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Healthcare Providers & Services company?
A good Non Operating Income depends on the Healthcare Providers & Services industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Veradigm and its competitors. Veradigm's current Non Operating Income is $-128.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (MDRX) has a current Non Operating Income of $-128.5 Mil. The current Non Operating Income is $-128.5 Mil. Veradigm's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Veradigm (MDRX), the current Non Operating Income is $-128.5 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veradigm Business Description

Address 222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
23GF Score

Get the complete analysis for MDRX

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.65
Price